Novel Interventions for Neurodevelopmental Disorders (R34)

Post Date

March 6th 2009

Application Due Date

May 12th 2009

Funding Opportunity Number

RFA-MH-09-160

CFDA Number(s)

93.242
93.273

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) .

Funding

• Estimated Total Funding:

  $2500000

• Award Range:

  $None - $225000

Grant Description

Purpose. This Funding Opportunity Announcement (FOA) solicits R34 grant applications that propose to develop novel interventions that will improve functioning in domains commonly affected by neurodevelopmental disorders. It provides resources for evaluating the feasibility, tolerability, acceptability and safety of novel approaches, and for obtaining the preliminary data needed to support the development of a larger-scale efficacy trial. This FOA is intended to encourage a broad scope of new treatment approaches with potential for widespread, cost-effective application across a variety of neurodevelopmental disorders based on the targeted domain(s) of functioning. The treatment approaches may include psychopharmacologic, other physiological, cognitive, psychosocial, psychoeducational, and behavioral approaches or novel combinations of any of these approaches. Also of interest are particularly innovative and theoretically-based intervention approaches currently in clinical use that have not been adequately evaluated for safety and tolerability. Mechanism of Support. This FOA will utilize the NIMH Clinical Exploratory/Developmental Research Grant (R34) award mechanism and runs in parallel with an FOA of identical scope, RFA-MH-09-161, which solicits applications using the Exploratory/Developmental Phased Innovation grant (R21/R33) award mechanism. The R21/R33 may be more appropriate for projects in an earlier phase of development, and includes resources for technical development and proof-of-principle projects.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-09-160.html